Tenaya Therapeutics, Inc. (TNYA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TNYA currently has 217M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 125.5% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 216.9M shares outstanding |
220M | 0 |
| Nov 10, 2025 |
10-Q filing | 163.3M shares outstanding |
160M | 0 |
| Aug 06, 2025 |
10-Q filing | 162.8M shares outstanding |
160M | 0 |
| May 07, 2025 |
10-Q filing | 162.7M shares outstanding |
160M | 0 |
| Mar 21, 2025 |
S-3 filing: Tenaya Therapeutics, Inc. files an S-3 form to offer common stock, preferred stock, debt securities, depositary shares, subscription rights and purchase contracts up to an aggregate offering price of $300,000,000. |
85M | 0 |
| Mar 10, 2025 |
10-K filing | 84.8M shares outstanding |
85M | 0 |
| Nov 06, 2024 |
10-Q filing | 86.2M shares outstanding |
86M | 0 |
| Aug 08, 2024 |
10-Q filing | 85.7M shares outstanding |
86M | 0 |
| May 14, 2024 |
10-Q filing | 81.0M shares outstanding |
81M | 0 |
| Mar 18, 2024 |
10-K filing | 73.8M shares outstanding |
74M | 0 |
| Nov 08, 2023 |
10-Q filing | 73.9M shares outstanding |
74M | 0 |
| Aug 09, 2023 |
10-Q filing | 73.4M shares outstanding |
73M | 0 |
| May 10, 2023 |
10-Q filing | 73.1M shares outstanding |
73M | 0 |
| Mar 08, 2023 |
10-K filing | 66.9M shares outstanding |
67M | 0 |
| Nov 10, 2022 |
10-Q filing | 41.4M shares outstanding |
41M | 0 |
| Aug 10, 2022 |
S-3 filing: Tenaya Therapeutics, Inc. files an S-3 form for a shelf offering of common stock, preferred stock, debt securities, depositary shares, subscription rights, and purchase contracts, with an aggregate offering price not to exceed $300,000,000. |
41M | 0 |
| Aug 10, 2022 |
10-Q filing | 41.4M shares outstanding |
41M | 0 |
| May 11, 2022 |
10-Q filing | 41.3M shares outstanding |
41M | 0 |
| Mar 23, 2022 |
10-K filing | 41.3M shares outstanding |
41M | 0 |
| Nov 10, 2021 |
10-Q filing | 41.3M shares outstanding |
41M | 0 |
| Sep 08, 2021 |
10-Q filing | 41.3M shares outstanding |
41M | 0 |
| Aug 03, 2021 |
8-K filing: Tenaya Therapeutics, Inc. announced the closing of its IPO of 13,800,000 shares of its common stock, which includes 1,800,000 shares that were offered and sold pursuant to the full exercise of the underwriters option to purchase additional shares. |
N/A | 0 |